BioSpeedia was founded by 2 renowned scientists from the Institut Pasteur in 2011: Evelyne Begaud, President and Yves Germani, Chief Scientific Officer.
Our clinical research is conducted at St-Priest-en-Jarez, France and clinical testing and quality control in Paris and St. Etienne, France. BioSpeedia is also in the process of relocating part of its overseas production to France.
Our global sales and distribution, product registration in various jurisdictions, liasing with regulatory authorities, logistics and shipping is handled by our distribution arm, BioVitess Ltd. which is located in Belfast, UK.
All business in the United States, including registration, liaising with regulatory authorities, sales and distribution is handled by our subsidiary BioSpeedia LLC. We also have our subsidiary in Switerland, BioSpeedia International.
Forepont provides BioSpeedia access to its global healthcare network, strategic relationships, and access to leading hospitals. Forepont’s Head of Europe, Julien Tizot, is also an Executive Board Member at BioSpeedia.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 1, Rue Gutenberg, Paris,île-De-France 75015,france
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://biospeedia.com/
- Keywords
- Cestas.
- HQ
- Paris, Île-de-France
Biospeedia Questions
Biospeedia's website is https://biospeedia.com/
Biospeedia's LinkedIn profile is https://fr.linkedin.com/company/biospeedia-global
Biospeedia has
2 employees.
View email and phone details for 2
employees at Biospeedia.
Biospeedia's industry is
Pharmaceutical Manufacturing
Biospeedia's categories are Pharmaceutical Manufacturing
Biospeedia's founding year is 2011
